70080
Myristic acid
≥98.5% (GC)
Synonym(s):
1-Tridecanecarboxylic acid, C14:0, NSC 5028, Tetradecanoic acid
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
CH3(CH2)12COOH
CAS Number:
Molecular Weight:
228.37
EC Number:
208-875-2
UNSPSC Code:
12352211
MDL number:
Beilstein/REAXYS Number:
508624
assay
≥98.5% (GC)
bp
250 °C/100 mmHg (lit.)
mp
52-54 °C (lit.), 53-56 °C
SMILES string
CCCCCCCCCCCCCC(O)=O
InChI
1S/C14H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h2-13H2,1H3,(H,15,16)
InChI key
TUNFSRHWOTWDNC-UHFFFAOYSA-N
Still not finding the right product?
Explore all of our products under Myristic acid
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Anja Meier et al.
Hepatology (Baltimore, Md.), 58(1), 31-42 (2012-12-06)
Chronic infection with the human hepatitis B virus (HBV) is a global health problem and a main cause of progressive liver diseases. HBV exhibits a narrow host range, replicating primarily in hepatocytes. Both host and hepatocyte specificity presumably involve specific
Dalit Shental-Bechor et al.
Proceedings of the National Academy of Sciences of the United States of America, 109(44), 17839-17844 (2012-08-01)
We present an integrated experimental and computational study of the molecular mechanisms by which myristoylation affects protein folding and function, which has been little characterized to date. Myristoylation, the covalent linkage of a hydrophobic C14 fatty acyl chain to the
Sarah Brice Russo et al.
The Journal of clinical investigation, 122(11), 3919-3930 (2012-10-02)
Diabetic cardiomyopathy (DbCM), which consists of cardiac hypertrophy and failure in the absence of traditional risk factors, is a major contributor to increased heart failure risk in type 2 diabetes patients. In rodent models of DbCM, cardiac hypertrophy and dysfunction